Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and efficacy of midazolam sedation in severe cardiopulmonary bypass patients
ChiCTR2100044020Phase 4Recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of midazolam in critical illness, cardiopulmonary bypass (CPB) and acute kidney failure (AKF) (3 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoint: Pharmacokinetics. Started Apr 2021; status: recruiting.
02
Drugs
midazolam
03
Conditions
critical illnesscardiopulmonary bypass (CPB)acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR2100044020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044020.